Phase II feasibility study of adjuvant s-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 1002)
研究実績
検索結果:
すべて の研究実績
Stage III胃癌に対する術後補助化学療法としての6か月間の ドセタキセル+S-1投与の検討(OGSG1002)
FU、プラチナ療法不応の進行再発食道癌に対するDOC療法とPTX療法の比較第II相試験(OGSG1201)
Randomized phase II study of CPT-11 versus PTX: +/- S1 in advanced gastric cancer refractory to S1 or S1 + platinum (OGSG0701)
Three-year outcomes of a phase Ⅱ study of adjuvant chemotherapy with S-1 plus docetaxel for stage Ⅲ gastric cancer after curative D2 gastrectomy
A Phase I/II Trial of Radiotherapy Concurrent with TS-1 Plus Cisplatin in Patients with Clinically Resectable Type 4 or Large Type 3 Gastric Cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group(OGSG1205)
A phase ll study of trastuzumab in combination with triweekly S-1 plus CDDP in HER2-positive advanced gastric cancer ; OGSG1101, HGCSG1102, T-CORE1101 Intergroup study (HERBIS-1 trial)
A phase ll study of trastuzumab in combination with triweekly S-1 plus CDDP in HER2-positive advanced gastric cancer ; OGSG1101, HGCSG1102, T-CORE1101 Intergroup study (HERBIS-1 trial)
A phase ll study of new combination regimen with trastuzumab, S-1 and CDDP in HER2- positive advanced gastric cancer; OGSG1101, HGCSG1102, T-CORE1101 Intergroup study (HERBIS-1 trial)
幽門側胃切除術における 予防抗菌薬投与に関する 第III相比較試験(OGSG0501)